PRESS RELEASES
SANOFI AT A GLANCE

Press releases

August 8, 2022
Press releases
Media Update: Tolebrutinib clinical trial program update
August 4, 2022
Press releases
Press Release: Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China
July 28, 2022
Press releases
Press Release: Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
July 14, 2022
Press releases
Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
July 10, 2022
Press releases
Press Release: Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis
ALL PRESS RELEASES

Contact the Media team

Global Media Relations Department
54 rue La Boétie
75008 Paris FRANCE
+33 (0)1 53 77 46 46 • mr@sanofi.com

ALL THE CONTACTS

You are a journalist and have a question about Sanofi, please contact the Global Media Relations team: please note the contact details are only for Medias. For any other request, please call the switchboard: +33 1 53 77 40 00

Email Alerts

Social feed

Resources

Sanofi at a glance

Publications

2020 Integrated Report

2020 Annual report on Form 20-F

Half year Financial report 2020

ALL THE PUBLICATIONS

Press Statements

Find out more about all our press statements